Brokerages Set Compass Therapeutics, Inc. (NASDAQ:CMPX) Target Price at $13.38
Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) has received an average recommendation of “Buy” from the nine ratings firms that are covering the company, Marketbeat.com reports. Eight investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among […]
Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) has received an average recommendation of “Buy” from the nine ratings firms that are covering the company, Marketbeat.com reports. Eight investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among […]
